Russell Investments Group, Ltd. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,360
-54.9%
102,301
-2.3%
0.00%
Q2 2023$136,092
-60.5%
104,688
-46.6%
0.00%
-100.0%
Q1 2023$344,793
+8.3%
195,906
+93.3%
0.00%0.0%
Q4 2022$318,273
-35.8%
101,3610.0%0.00%0.0%
Q3 2022$496,000
+259.4%
101,361
+203.5%
0.00%
Q2 2022$138,000
-85.7%
33,400
-57.0%
0.00%
-100.0%
Q1 2021$964,000
-43.9%
77,714
-29.4%
0.00%
-33.3%
Q4 2020$1,717,000
+55.5%
110,083
-5.8%
0.00%
+50.0%
Q3 2020$1,104,000
+13.7%
116,871
+7.8%
0.00%0.0%
Q2 2020$971,000
+166.8%
108,371
+89.2%
0.00%
+100.0%
Q1 2020$364,000
-57.0%
57,280
-43.5%
0.00%
-50.0%
Q4 2019$846,000
-7.7%
101,2920.0%0.00%0.0%
Q3 2019$917,000
-14.3%
101,292
+1.8%
0.00%0.0%
Q2 2019$1,070,000
+12.9%
99,4590.0%0.00%0.0%
Q1 2019$948,000
-16.8%
99,4590.0%0.00%
-33.3%
Q4 2018$1,139,000
-36.5%
99,459
-6.1%
0.00%0.0%
Q3 2018$1,795,000
+252.7%
105,894
+194.9%
0.00%
+200.0%
Q2 2018$509,000
-25.4%
35,9100.0%0.00%0.0%
Q1 2018$682,000
+2.6%
35,910
-7.8%
0.00%0.0%
Q4 2017$665,000
-37.3%
38,955
-44.9%
0.00%
-50.0%
Q3 2017$1,060,000
+422.2%
70,674
+206.0%
0.00%
Q2 2017$203,000
+13.4%
23,095
-60.7%
0.00%
Q4 2016$179,00058,7390.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders